<DOC>
	<DOCNO>NCT02170870</DOCNO>
	<brief_summary>To understand patient indigestion without diabetes gastrointestinal symptom particular understand symptom relate increased sensitivity nutrient .</brief_summary>
	<brief_title>Gastrointestinal Sensorimotor Dysfunctions Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<criteria>Inclusion criterion control Healthy male nonpregnant , nonbreastfeeding female volunteer ; 1870 year old ; Able provide write informed consent participate study ; Able communicate adequately investigator comply requirement entire study Additional inclusion criterion patient Symptoms dyspepsia ( i.e. , early satiety , postprandial discomfort , nausea , vomit , regurgitation ) Patients DM group also require Type 1 2 DM ≥ 3 year duration ; patient type 2 DM , dyspepsia symptom begin worsen DM diagnose Total serum lipase ≥ 10 IU/ml Exclusion criterion patient control Major abdominal surgery ( i.e. , appendectomy , cholecystectomy , tubal ligation , hysterectomy , limited colonic resection permissible ) Clinical evidence ( include physical exam EKG ) significant cardiovascular , respiratory , renal , hepatic , gastrointestinal , hematological , neurological , psychiatric disease may interfere objective study and/or pose safety concern Opiates , alpha adrenergic agonist , metoclopramide , high dos anticholinergic agent ( eg , amitriptyline great 50 mg daily ) . If medically safe , drug may discontinue four half live prior study assessment Treatment GLP1 agonists amlyin cause vagal blockade may affect central processing pain Use tobacco product within past six month NSAIDs aspirin within past week ( since may affect intestinal permeability ) Bleeding clot disorder medication increase risk bleed mucosal biopsy Positive tissue transglutaminase antibody ( TTG ) , serum lipase &lt; 10IU/L For two day prior study , subject instruct avoid ingestion artificial sweetener SplendaTM ( sucralose ) , NutrasweetTM ( aspartame ) , food contain lactulose mannitol Pregnant breastfeeding female Known intolerance allergy egg Poor peripheral venous access , central venous access available Any condition prior therapy , opinion investigator , would make patient unsuitable study Exclusion criterion control • Current symptom functional gastrointestinal disorder assess questionnaire Exclusion criterion patient Severe vomit would preclude tube placement participation study Structural cause symptom endoscopy within past 48 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>